Compare DGLY & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGLY | ADXN |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 10.0M |
| IPO Year | N/A | N/A |
| Metric | DGLY | ADXN |
|---|---|---|
| Price | $0.71 | $7.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 815.2K | 7.8K |
| Earning Date | 03-31-2026 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,097,965.00 | $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | $7.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.81 | $6.51 |
| 52 Week High | $1,320.00 | $12.05 |
| Indicator | DGLY | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 25.60 | 47.30 |
| Support Level | $1.27 | $7.01 |
| Resistance Level | $1.41 | $8.30 |
| Average True Range (ATR) | 0.11 | 0.43 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 2.04 | 41.41 |
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.